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characterisation of phosphoroselenolate-modiﬁed
DNA: a backbone analogue which does not impose
conformational bias and facilitates SAD X-ray
crystallography†
Patrick F. Conlon, a Olga Eguaogie, a Jordan J. Wilson, a Jamie S. T. Sweet, a
Julian Steinhoegl, b Klaudia Englert,c Oliver G. A. Hancox, b Christopher J. Law,d
Sarah A. Allman, b James H. R. Tucker, c James P. Hall *be
and Joseph S. Vyle *a
Oligodeoxynucleotides incorporating internucleotide phosphoroselenolate linkages have been prepared
under solid-phase synthesis conditions using dimer phosphoramidites. These dimers were constructed
following the high yielding Michaelis–Arbuzov (M–A) reaction of nucleoside H-phosphonate derivatives
with 50-deoxythymidine-50-selenocyanate and subsequent phosphitylation. Eﬃcient coupling of the
dimer phosphoramidites to solid-supported substrates was observed under both manual and automated
conditions and required only minor modiﬁcations to the standard DNA synthesis cycle. In a further
demonstration of the utility of M–A chemistry, the support-bound selenonucleoside was reacted with an
H-phosphonate and then chain extended using phosphoramidite chemistry. Following initial unmasking
of methyl-protected phosphoroselenolate diesters, pure oligodeoxynucleotides were isolated using
standard deprotection and puriﬁcation procedures and subsequently characterised by mass
spectrometry and circular dichroism. The CD spectra of both modiﬁed and native duplexes derived from
self-complementary sequences with A-form, B-form or mixed conformational preferences were
essentially superimposable. These sequences were also used to study the eﬀect of the modiﬁcation
upon duplex stability which showed context-dependent destabilisation (0.4 to 3.1 C per
phosphoroselenolate) when introduced at the 50-termini of A-form or mixed duplexes or at juxtaposed
central loci within a B-form duplex (1.0 C per modiﬁcation). As found with other nucleic acids
incorporating selenium, expeditious crystallisation of a modiﬁed decanucleotide A-form duplex was
observed and the structure solved to a resolution of 1.45 A˚. The DNA structure adjacent to the
modiﬁcation was not signiﬁcantly perturbed. The phosphoroselenolate linkage was found to impart
resistance to nuclease activity.Introduction
The automated solid-phase synthesis of oligonucleotides using
phosphoramidite chemistry1 (Fig. 1A) is a platform technology
which has been transformative in a wide range of applications2ing, Queen's University Belfast, David Keir
, UK. E-mail: j.vyle@qub.ac.uk
eading, Whiteknights, Reading RG6 6AP,
am, Edgbaston, Birmingham B15 2TT, UK
rsity Belfast, 15 Chlorine Gardens, Belfast
fordshire, OX11 0DE, UK
ESI) available: PDB ID: 6S7D. See DOI:
Chemistry 2019including the measurement3,4 and manipulation5,6 of gene
expression, DNA nanotechnology7,8 and data storage.9
Whilst simple Watson–Crick base-pairing rules can be used
to programme both intramolecular and intermolecular
assembly of three-dimensional structures from simple
duplexes,10,11 the tertiary interactions of folded nucleic acids
derived from more complex assemblies and their recognition,
especially by nucleic acid binding proteins or small molecule
eﬀectors, typically requires structural elucidation at the atomic
level.12,13 Characterisation of novel structural motifs including
such complexes by X-ray crystallography is augmented by the
introduction of an anomalous heavy atom scattering centre.14,15
Anomalous scattering of X-rays at the Se–K edge has been of
considerable value in facilitating structural biology studies of
proteins following the pioneering work of Hendrickson and co-Chem. Sci.
Fig. 1 (A) General scheme for the solid-phase synthesis of oligonucleotides using phosphoramidite chemistry. (B) Examples of selenium-
modiﬁed nucleic acid analogues prepared using this chemistry.
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View Article Onlineworkers using either selenomethionine16 or a high-aﬃnity
ligand.17 The molecular biology techniques required to engi-
neer polypeptide sequences containing a mutated selenome-
thionine residue have now become routine and as this residue
does not disrupt protein folding, it is widely used in MAD
(multiple wavelength anomalous dispersion) or SAD (single
wavelength anomalous diﬀraction) applications.18 Concurrent
increased access to third generation synchrotron sources which
generate more focussed, tunable X-rays of high brightness and
stability coupled with automation of the screening of crystal-
lisation conditions has engendered a considerable upsurge in
protein crystal structure solution such that in the year 1990, 132
protein structures were deposited in the protein databank
whereas in 2018 this number had risen to 10 306. Of the 137 000
protein crystal structures in the PDB repository by the end of
2018, over 10% had been solved using SAD or MAD methods.
These methodologies are particularly important for “rst inChem. Sci.class” structures of proteins and nucleic acids, where new
structural folds or ligand-induced distortions exclude using
other approaches to structure solution such as molecular
replacement (which relies upon prior knowledge of a structure
based upon its sequence). However, the true impact of using Se-
SAD and Se-MADmay never fully be known as once the structure
of a new fold or motif has been determined, this can then be
used as the basis for solving future structures without requiring
anomalous data. SAD and MAD phasing is therefore a great
facilitator of structural science and is used in drug development
programmes worldwide, due to the expeditious ability to
determine pharmacophore–target interactions. However, for
a structure to be biologically “valid” the incorporation of a heavy
atom (such as Se or Br) into the crystal needs to have little or no
eﬀect on the conformation or topology of the molecule, whilst
also not modifying the molecular arrangement of any potential
binding sites. This is a particular problem when working withThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinenucleic acids as the most commonly used nucleotide analogues,
which contain heavy atom groups, either alter the topology of
the nucleic acid (shiing its conformation) or change the
groups present in either the major or minor groove, both of
which are binding sites for most DNA-targeting drugs.
Methodology for the synthesis of selenium-modied nucleic
acid (Fig. 1B) sequences under solid-phase conditions was rst
described three decades ago.19 In this report, selenisation of
support-bound H-phosphonate precursors required treatment
every 3–4 hours over three or four days and gave mixtures of the
diastereomeric phosphoroselenoates. Subsequently, more eﬃ-
cient selenisation protocols20,21 and stereoselective synthesis22
have been developed and this modication has enabled the
solution of refractory structures such as homo-DNA.23 However,
the sensitivity of intermediates during oligomerisation and
short half-life of the nal product (ca. 30 days under ambient
conditions in aqueous solution) has limited their application,
especially in vivo. Likewise, nucleobase analogues which
incorporate a selenone function can be accessed using concise
synthetic pathways24–28 but are sensitive towards oxidation,
hydrolysis and photochemical degradation.
A third class of selenium-modied oligonucleotides in which
selenoether functions have been introduced at the 20,29–32 40,33,34
or terminal 50-positions35 or appended to a nucleobase36 exhibit
greater resilience towards the conditions typically employed
during standard solid-phase oligonucleotide synthesis using
phosphoramidite chemistry although mitigation of side-
reactions arising from selenoether oxidation is required37,38
and replacement of an oxygen at a stereogenic centre provides
additional synthetic demands, e.g., up to 14-steps are required
to prepare 40-seleno-40-deoxynucleosides from D-ribose.39,40 The
20-selenomethyl ether analogues (especially pyrimidine deriva-
tives) are considerably more accessible (requiring only six steps
to prepare on large scale)41 and can also promote crystallisation
of modied oligomers.29,42–45 However, although the furanoside
ring of individual nucleosides modied in this fashion adopt
a conformation typically found in B-form DNA,46 when incor-
porated into oligodeoxynucleotide duplexes, the location of the
20-selenomethyl function in the minor groove provides confor-
mational steering towards the formation of RNA-like A-form
duplexes. Although the epimeric arabino-20-selenomethyl
analogue reverses this trend,31 full details of its preparation
have not yet been reported and the steric bulk of both isomers
can interfere with groove-binding interactions.46
Replacement of a bridging oxygen (30 or 50) within an inter-
nucleotide phosphate diester by selenium gives rise to phos-
phoroselenolate analogues. These are achiral and potentially
more stable than the corresponding phosphoroselenoates but
have been documented in only a very limited number of
communications.47–49
Alkylation of the lead salt of O,O-diethylphosphoroselenoate
was rst reported in 1911 50 and this strategy has been applied
to the preparation of internucleotide phosphoroselenolate
linkages using 50-halothymidine derivatives either in DMF47 or
under aqueous conditions.48 In the former case, character-
isation of the dimer product was equivocal indicating that
perhaps both O- and Se-alkylation had occurred.51–53This journal is © The Royal Society of Chemistry 2019Subsequently, Xu and Kool exploited related chemistry for the
synthesis of oligomers incorporating this analogue following
template-directed chemical ligation. However, consistent with
the extreme sensitivity of phosphoroselenoate monoesters
towards ariel oxidation in aqueous solution,54 incomplete
reaction was observed. In contrast, Michaelis–Arbuzov (M–A)
reaction of a nucleoside 30-H-phosphonate with a 50-selenocya-
nate enabled synthesis of a fully-characterised
phosphoroselenolate-bridged dimer (TpSedT) with high
eﬃciency.49
Herein, we describe the further developments to this meth-
odology enabling the isolation of pure dinucleoside phosphor-
oselenolate triesters in good to excellent yields, their
subsequent phosphitylation and eﬃcient introduction into
oligodeoxynucleotides under solid-phase conditions. Further-
more, we report a model DNA crystal structure incorporating
this modication which evinces an A-form morphology with
minimal perturbation of the backbone.Results and discussion
Preparation of dinucleotide phosphoramidites
The protected M–A product from the synthesis of TpSedT49
appeared to be an attractive target as eﬃcient dimer coupling
has been reported during the solid-phase construction of
oligonucleotides containing sulfur.55,56 Furthermore, this
strategy would avoid the preparation and use of intermediates
containing a labile chalcogen–P(III) bond.57,58 We therefore
sought to optimise the synthesis and isolation of the protected
dinucleoside phosphoroselenolate triester from the corre-
sponding selenocyanate.
50-Deoxythymidine-50-selenocyanate has been prepared on
small scales in solution over 24 hours 59 or using liquid assisted
grinding over 9–11 hours.60,61 In order to prepare this material
more eﬃciently, we therefore examined the application of
microwaves which has been reported to enhance the rate of S-
selective alkylation of the thiocyanate anion.62 In the presence
of excess potassium selenocyanate, clean transformation of 50-
tosylthymidine (1) into the corresponding 50-selenocyanate (2)
was observed within 90 minutes following irradiation (20 W,
100 C) of the stirred reaction mixture in acetonitrile (Scheme
1). As previously observed,60 quenching of the excess seleno-
cyanate with benzyl bromide greatly facilitated subsequent
purication by silica gel chromatography and pure 50-deoxy-
thymidine 50-selenocyanate (2) was isolated in 75% yield.
During optimisation of both the reaction conditions and
subsequent purication of the M–A product derived from 2 and
cyanoethyl-protected nucleoside 30-H-phosphonate diesters,
several issues became apparent. Specically, the neutral sily-
lating agent, N,O-bis(trimethylsilyl)acetamide (BSA), which
served both to render the selenonucleoside soluble in chloro-
form and enhance the rate of the M–A reaction also promoted
decyanoethylation of both the starting material and the
product. Furthermore, subsequent quenching of the reaction
following addition of water resulted in detritylation in the
absence of a strong organic base but if such a base was usedChem. Sci.
Scheme 1 Preparation of dinucleotide phosphoramidites 5a–d. Reagents and conditions: (a) (i) KSeCN (1.5 eq.), MeCN, MW power 20W, 100 C,
90min; (ii) BnBr (0.6 eq.), MeOH, rt, 60min. (b) 3a–e (1.5 eq.), 2,6-lutidine (5 eq.), MeCN, rt, 30–60min. (c) (i) ClP(OCE)NiPr2 (2 eq.), iPr2NEt (3 eq.),
DCM, rt, 45min; (ii) MeOH (1.5 eq.), rt, 15min. *in MeCN (4d) or DCM, ‡in DMSO-d6. Key. Base
PG. AdePAc: 9-(N6-phenoxyacetyladeninyl). CytAc: 1-
(N4-acetylcytosinyl). GuaiBu: 9-(N2-isobutyrylguaninyl). Thy: 1-thyminyl. DMTr: 4,40-dimethoxytrityl. MMTr: 4-methoxytrityl CE: 2-cyanoethyl. p:
P(O)OMe. Ts: p-toluenesulfonyl.
Fig. 2 31P{1H} NMR of phosphoramidite 5a (prepared from DMTrdA-
PAcpSedT – 4a) in MeCN with (inset) expansions of resonances asso-
ciated with P(III) and P(V) nuclei.
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
O
ct
ob
er
 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
1/
4/
20
19
 1
:4
8:
29
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineduring work-up, further decyanoethylation of the phosphor-
oselenolate was evident.63
In order to ameliorate issues associated with b-elimination of
the cyanoethyl function, methyl-protection of the phosphate was
adopted. This provides greater resilience towards phosphate
deprotection in the presence of stronger organic bases such as
triethylamine and has recently been utilised for the preparation of
di- and trinucleotide phosphoramidites.63–65 Themethyl-protected
30-H-phosphonates (3a–e) were prepared from the corresponding
phosphoramidites under modied literature conditions.66
Following extractive work-up, thematerials were pure by 31P NMR.
However, in our hands, theseH-phosphonates were less stable
towards dephosphonylation than those derived from the
cyanoethyl-protected precursors and low levels of the nucleoside
congeners were identied by TLC as contaminants. Thus, once
isolated, the solids were stored at 20 C and used within 24
hours. To accommodate the presence of these impurities, excess
H-phosphonate (1.5 eq.) was used in the M–A reaction. In
a further change to the previous published procedure, acetoni-
trile was used as solvent and in the presence of 2,6-lutidine,
nucleoside selenocyanate 2 could be dissolved in this mixture
under gentle heating without silylation. Addition of this solution
to thymidine H-phosphonate (3d) in acetonitrile at room
temperature gave complete and clean M–A reaction within 30
minutes. We note that these conditions contrast with those
typically employed to promote such reactions with chalcogen
electrophiles following conversion of theH-phosphonate into the
corresponding phosphite tautomer in the presence of a silylating
agent or a strong base. The protected dimers (4a–e) were isolated
as mixtures of diastereoisomers following silica gel column
chromatography. Phosphitylation of the dimers under modied
literature conditions67 enabled isolation of the corresponding
phosphoramidites derived from 50-dimethoxytrityl-protected dAChem. Sci.(5a), dC (5b) or T (5d) and 50-monomethoxytrityl-protected dG (5c)
in greater than 70% yields. During attempted processing of 4e
(DMTrdGiBupSedT) under the same conditions, detritylation was
evident and therefore further reaction to the corresponding
phosphoramidite was not attempted.
Analysis of the dimer phosphoramidites by 31P NMR showed
expected resonances associated with two separate diastereo-
meric P(III) and P(V) phosphorus centres (e.g., Fig. 2). Low levels
(<4%) of putative H-phosphonate derivatives were also apparent
and as this can be associated with autocatalytic degradation,68,69
the stability of a dimer phosphoramidite in solution was
examined by 31P NMR. At 4 C, 5a (0.1 M in acetonitrile)This journal is © The Royal Society of Chemistry 2019
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View Article Onlineremained untransformed over 24 days. A separately prepared
solution of the same composition was stored on the DNA syn-
thesiser at ambient temperature. Aer 24 days, solid deposition
was observed and 31P NMR analysis of the combined materials
(solid and liquid) showed over 80% degradation of the phos-
phoramidite although no transformation of the phosphor-
oselenolate function was evident.Fig. 3 31P{1H} NMR of ODN 1 in 60 : 40 (v/v) H2O : D2O and (inset)
ESI-mass spectrum showing isotope pattern associated with molec-
ular ion.Preparation of phosphoroselenolate-modied
oligodeoxynucleotides under solid-phase conditions via
coupling of dimer phosphoramidites
Optimisation of solid-phase synthesis conditions was per-
formed with the dimer phosphoramidite 5d (derived from
DMTrdTpSedT) using manual syringe addition of all reagents
and acetonitrile washes to prepare a model homothymidine-
derived pentamer incorporating two phosphoroselenolate
linkages (ODN 1 – Table 1). Under optimised conditions,
quantitative coupling (by trityl release) of 5d in the presence of
the activator 5-S-benzylthiotetrazole was observed over ve
minutes with subsequent oxidation using 0.02 M iodine.
Duplicate, one mmol-scale syntheses of the trityl-on, model
pentamer were performed. Removal of phosphate diester pro-
tecting groups and cleavage from the controlled pore glass
(CPG) support required a two-step procedure. Initial demethy-
lation of the phosphoroselenolate triesters was eﬀected
following treatment with a solution of 0.2 M sodium dieth-
yldithiocarbamate (NaDEC) in acetonitrile for 30 minutes at
room temperature. This method was found to be equally eﬃ-
cient in a side-by-side comparison with standard literature
conditions using 1 : 2 : 2 (v/v/v) thiophenol/triethylamine/
dioxane.55 Excess reagents were removed following washing
with acetonitrile, the CPG dried and suspended in 1 : 1 (v/v)
35% (w/v) NH3 (aq)/40% (w/v) MeNH2 (aq) (AMA) at room
temperature for 60 minutes. Following removal of volatile
amines, the crude tritylated oligomer ODN 1 was puried using
reversed phase HPLC. Finally, treatment with aqueous acetic
acid under standard conditions eﬀected cleavage of the 50-DMTr
function and following desalting, pure ODN 1 was isolated in
33% yield. Analysis of ODN 1 by 31P NMR (Fig. 3) showed four
resonances associated with the two internucleotide phosphate
diesters (dP ¼ 1.19, 1.25) and two internucleotide phos-
phoroselenolate diesters (dP ¼ 10.56, 10.48).
Satellite peaks associated with 31P–77Se coupling were
consistent with a phosphorus–selenium single bond (1JPSe ¼Table 1 Phosphoroselenolate-modiﬁed oligodeoxynucleotide sequences
Phosphoramidite (coupling time) Oligodeoxynucleotide seque
5d (5 min) ODN 1 d(TSeTTSeTT)
5a (2  7.5 min) ODN 2 d(ASeTCCCGGGAT)
5b (2  7.5 min) ODN 3 d(CSeTCCCGGGAG)
5c (2  7.5 min) ODN 4 d(GSeTCCCGGGAC)
5d (5 min) ODN 5 d(TSeTCCCGGGAA)
5a (2  7.5 min) ODN 6 d(CGCGAASeTTCGC
a Determined using 3260 nm of the corresponding native sequence on a 2 m
This journal is © The Royal Society of Chemistry 2019393 Hz and 390 Hz)70 although somewhat weaker than that
found in the corresponding triester.
ODN 1 was further characterised using ESI-MS (Fig. 3 – inset)
which gave a molecular ion peak ([M  H]) displaying the ex-
pected isotope distribution pattern.
In order to further examine the scope of the manual dimer
phosphoramidite coupling and deprotection protocol devel-
oped for ODN 1, a series of self-complementary 10-mer
sequences designed to form A-form duplexes (ODN 2–5) were
prepared. Chain extension of support-bound octanucleotides
using phosphoramidite 5d was performed using the same cycle
as previously described. However, less eﬃcient couplings were
observed using 5a–c and therefore an extended double
coupling71 was employed with these phosphoramidites.
Following oxidation, the columns were washed with aceto-
nitrile and dried under argon. Deprotection using NaDEC fol-
lowed by AMA liberated the crude, tritylated
oligodeoxynucleotides which were puried by RP-HPLC and
reduced in vacuo. Detritylation of the puried oligomers was
accomplished under literature conditions using an extended
treatment to fully remove the monomethoxytrityl function from
ODN 4.
The modied Dickerson–Drew dodecamer72 sequenceODN 6
was prepared under automated conditions using the
phosphoroselenolate-linked dimer phosphoramidite 5a which
was incorporated in place of the central AT motif. In addition to
the extended coupling of 5a, the standard cycle was modied toprepared on solid support using dinucleotides phosphoramidites 5a–d
nce 50/30 Yielda (%) Mol. ionb (calcd)
657 nmol (33%) 1585.070 (1585.112)
541 nmol (27%) 3090.370 (3090.472)
251 nmol (13%) 3091.365 (3091.468)
484 nmol (24%) 3091.351 (3091.468)
337 nmol (17%) 3090.360 (3090.472)
G) 198 nmol (20%)* 3708.450 (3708.450)
mol scale (* from 1 mmol). b m/z [M  H] (80Se).
Chem. Sci.
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View Article Onlineinclude a wash using 10% (v/v) pyridine/MeCN following the
oxidation step. In the absence of this wash, the CPG retained
iodine residues which were found to engender lower yields of
the modied oligomers. The subsequent ve monomer
coupling cycles were performed under standard conditions and
gave eﬃcient nucleotide incorporation according to trityl yields.
Once complete, the support-bound dodecamer was
treated with a solution of 150mMdithiothreitol (DTT) in 1 : 1 (v/v)
H2O : absolute ethanol to remove potential oxidised selenium
species37,45 and further demethylated using NaDEC as previously
described. Further deprotection with AMA enabled the pure trityl-
on oligomer to be isolated following RP-HPLC purication. This
material was then detritylated and desalted under standard
conditions to aﬀord pure ODN 6 in 20% yield. Under the same
conditions the corresponding native sequence was isolated in
45% yield. All selenium-containing oligodeoxynucleotides were
characterised by mass spectrometry in which the m/z ratios
exhibited the expected isotope distribution patterns and did not
show any peaks associated with selenoxide formation.
Preparation of a model phosphoroselenolate-modied
oligodeoxynucleotide under solid-phase conditions via
Michaelis–Arbuzov chemistry
In order to demonstrate the general utility of the M–A reaction
for constructing internucleotide phosphoroselenolates under
solid-phase conditions, this chemistry was used to prepare
a tetranucleotide sequence which, in its native form, crystallises
in the four-stranded, i-motif conformation.73,74 Thus,ODN 7was
prepared from the corresponding support-bound nucleoside
selenocyanate (Scheme 2). Succinylation of selenonucleoside 2
under standard conditions75 gave complete consumption of
starting material. Following extraction with cold citric acid, the
succinyl ester (6) was isolated contaminated with the corre-
sponding symmetrical diselenide (30 mol%). This crude mate-
rial was treated with excess condensing agent (DCC) in the
presence of 4-nitrophenol76 and following removal ofScheme 2 Preparation of ODN 7. Reagents and conditions: (a) suc-
cinic anhydride (1 eq.), DMAP (0.8 eq.), pyridine, rt, overnight; (b) (i) p-
nitrophenol (1 eq.), DCC (2.5 eq.), DCM, rt, 2 h; (ii) amino SynBase 500/
110 CPG (500 mg), DMF, Et3N (4 eq.), rt, 5 h. (c) 3f, MeCN, rt, 1 h; (d)
solid-phase DNA synthesis using manual syringe addition. (e) (i) AMA,
rt, 2 h. (ii) 80% AcOH, rt, 1 h. See ESI† for full details.
Chem. Sci.precipitated DCU, the mixture of activated esters reacted with
amino-functionalised controlled pore glass. The CPG-bound
selenonucleoside (7) thus obtained was reacted with the
nucleoside H-phosphonate 3f. Aer 60 minutes, trityl assay
indicated that the support loading (39 mmol g1) was consistent
with that typically used in solid-phase DNA synthesis indicating
that eﬃcient M–A reaction had occurred.
Using this material (1.75 mmol), chain extension was per-
formed under manual conditions using standard monomer
phosphoramidites using the cycle developed for ODN 1.
Subsequent deprotection with AMA liberated the crude trity-
lated tetramer which was puried by RP-HPLC, detritylated and
desalted to aﬀord pure ODN 7.Enzymatic digestion
Further conrmation of the integrity of the internucleotide
phosphoroselenolate linkage during both coupling and down-
stream processing was provided by enzymatic digestion of both
ODN 5 and the corresponding native sequence. Using
commercially-sourced snake venom with both phosphodies-
terase and phosphatase activities, complete digestion of the
native 10-mer to the corresponding nucleosides was found
within eight hours at 37 C (Fig. S2†). Under the same condi-
tions, ODN 5 liberated the nucleosides dA, dC and dG in the
expected ratios but less than 1 mol% of T (tR ¼ 18.1 min) was
observed (Fig. 4). However, a single major peak with signi-
cantly longer retention time (tR¼ 38.7 min) was identied as the
dimer TpSedT following coinjection with an authentic sample.49
Previously, Stec and coworkers examined nuclease digestion of
putative TpSedT and described using ten times the quantity of
enzyme required to eﬀect cleavage of the corresponding phos-
phorothioate substrate. During this treatment, formation of the
corresponding diselenide; (SedT)2, was observed and this
compound is assumed to be the origin of a novel hydrophobic
material (tR ¼ 45.1 min) which was also apparent during
extended treatment of pure TpSedT with snake venom. Early
studies on the digestion of dimers incorporating a 50-thio-
thymidylate (e.g., TpSdT) also reported slow cleavage activi-
ties77,78 although Xu and Kool subsequently described snake
venom digestion of a 20-mer containing a single internal
modication which was shown to proceed at essentially theFig. 4 RP-HPLC chromatogram of the snake venom digest of ODN 5
(after 8 hours at 37 C). For full conditions see ESI.†
This journal is © The Royal Society of Chemistry 2019
Fig. 5 CD spectra comparing the conformation of phosphor-
oselenolate-modiﬁed sequences ( ) and the corresponding native
(all phosphodiester) sequences ( ). (A) ODN 4; (B) ODN 6.
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View Article Onlinesame rate as the unmodied sequence and cleaved the internal
phosphorothiolate linkage.79
Although the scissile bond (30O–P) is not modied in the
phosphoroselenolate analogues examined in this study, it is
assumed that distortion in the phosphoryl moiety arising out of
the extended bond lengths and compressed bond angle asso-
ciated with the P–Se–C50 bridge (vide infra) inhibits productive
binding of the dimer.
UV thermal denaturation studies
The eﬀect of the phosphoroselenolate linkage upon duplex
stability was investigated by comparing thermal denaturation of
the modied oligomers with the corresponding native
sequences (Table 2). Sequence-dependent destabilisation of
duplexes designed to exhibit A-form conformations was
observed following phosphoroselenolate substitution of the 50-
terminal phosphodiester linkage (entries 1–4). The largest
reductions in melting temperatures were observed for
sequences in which the native oligomers had the greatest
stabilities by virtue of the presence of a terminal C–G (entry 2) or
G–C (entry 3) base pair and in these circumstances, DTm values
of6.2 C and4.9 C (respectively) were observed. In contrast,
introduction of a phosphoroselenolate-linkage downstream
from a terminal A–T base pair (entry 1) had a minor eﬀect upon
duplex stability (DTm ¼ 0.7 C) although the eﬀect upon the
T–A (entry 4) pairing was more signicant (DTm ¼ 4.0 C).
The eﬀect of introducing juxtaposed phosphoroselenolate
bridges into the more extended backbone typical of B-form
helices was tested using the Dickerson–Drew dodecamer
sequence ODN 6 (entry 5). A decrease in stability of 1.9 C was
observed in comparison with the native oligomer. Xu and Kool
reported the eﬀect upon duplex stability of substituting a single
internal phosphate diester-linkage within a 17-mer (B-form)
sequence with either a phosphorothiolate or phosphor-
oselenolate analogue.48 Duplexes formed between these
chalcogen-modied oligomers and the native compliment dis-
played DTm values of 3.0 C (Se) and 2.0 C (S). These values
are consistent with those obtained in the current study in which
two modications are introduced per duplex.
Solution phase conformation studies
The eﬀects of introducing the phosphoroselenolate modica-
tion upon the conformations of self-complementary duplex
DNA sequences were investigated using circular dichroism. The
spectral shape and peak positions of native and modiedTable 2 Melting temperatures (Tm) of self-complementary phosphorose
Entry Sequence 50/30 X ¼
1 d(AXCCCGGGAT) SedT (ODN 2)
2 d(CXCCCGGGAG) SedT (ODN 3)
3 d(GXCCCGGGAC) SedT (ODN 4)
4 d(TXCCCGGGAA) SedT (ODN 5)
5 d(CGCGAAXTCGCG) SedT (ODN 6)
a DTm ¼ Tm(X ¼ SedT)  Tm(X ¼ T). Conditions: ssDNA (10 mM), NaPi (10
This journal is © The Royal Society of Chemistry 2019duplexes displayed a high level of congruence, with only small
changes in band intensity observed (Fig. S5–S9†). For example,
conservation of the mixed A/B conformation adopted in solu-
tion by ODN 4 (Fig. 5A) highlights that the modication is not
perturbing or directing the conformation of the duplex in
a boarderline case.
The advantage of the phosphoroselenolate modication over
ribosemodications, such as replacement of Owith Se in the ring,
which typically leads to formation of an A-formduplex,33 is clear. It
should also be noted that both the native and modied dodeca-
mer (Fig. 5B) exhibited the classical B-form again illustrating that
the modication has had little eﬀect on the solution conforma-
tion of the oligonucleotide. In all cases the incorporation of the Se
into the DNA backbone means that the environment in the major
and minor grooves is unaﬀected, unlike with modications such
as 5-bromo-dU or most selenium modied DNA. Whilst some of
these modications (such as a 20-SeMe analogues)42 may not
signicantly aﬀect the native conformation if this is A-form DNA,lenolate-modiﬁed and native oligodeoxynucleotide duplexes
Tm/C X ¼ Tm/C DTma/C
46.9 T 47.6 0.7
48.1 T 54.3 6.2
50.7 T 55.6 4.9
43.0 T 47.0 4.0
55.9 T 57.8 1.9
mM, pH 7.0), NaCl (100 mM).
Chem. Sci.
Fig. 6 (A) (left) The DNA structure reported here (ODN 4) and (right)
a standard A-form DNA 10-mer.81 (B) The phosphoroselenoate
modiﬁcation (cyan) compared with (C) the naturally occurring back-
bone at the terminal AC step. The chains are coloured according to
atom type, with carbon in red, green, cyan or magenta (as a function of
DNA chain), nitrogen in blue, oxygen in red, selenium in cyan, phos-
phorus in orange and hydrogen in white. PDB ID: 6S7D.†
Chemical Science Edge Article
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View Article Onlinethe addition of groups into possible binding sites could aﬀect the
validity of drug–DNA binding studies, which is not an issue with
a phosphoroselenolate modication.Crystal structure
To conrm that the structure of the nucleic acid is not signi-
cantly perturbed by the introduction of a phosphoroselenolate
modication, crystallisation trials of oligodeoxynucleotide
sequences containing the group were performed. This resulted
in the crystal structure of d(GSeTCCCGGGAC) – ODN 4 – being
obtained, which allows for visualisation of the modication at
1.45 A˚ resolution.
The structure shows that the overall conformation of the
duplex is that of A-DNA (Fig. 6A). The average twist of the helix is
31.8 which compares favourably to a standard value of 32.7.
However, at the modication site the T*–A base pair has a twist
of ca. 41, which can be attributed to the increased bond lengths
from P–Se (2.25 A˚) and Se–C50 (1.94 A˚) compared to the oxygen-
containing equivalent (P–O50 1.60 A˚, O50–C50 1.42 A˚).
Apart from this slight increase in bond lengths, and subse-
quent increase in helical twist angle, the base pair containing
the phosphoroselenolate modication is otherwise consistent
with a standard A-DNA base pair (Fig. 6B and C), with param-
eters such as roll, tilt, rise and slide all within the normal range
for this conformation (analysis performed using W3DNA).80
Whilst it could be expected that the increased twist or bond
lengths could aﬀect the sugar pucker of the nucleotide, this isChem. Sci.not the case, with the nucleotide possessing a C30-endo sugar
pucker, consistent with that of A-DNA.
The nucleotide 30 to the modied base also possesses a C30-
endo pucker. The base 50 to the modication site possesses
a non-standard pucker, C20-exo, which is attributed to the
proximity of a neighbouring strand, forming a crystal contact
within the lattice. This structure therefore conrms that the
introduction of the modication does not signicantly perturb
the solid-state conformation of the duplex.Conclusions
For the rst time, a phosphoroselenolate-modied oligomer
has been prepared de novo using phosphoramidite chemistry
with only minor modication to the standard solid-phase DNA
synthesis cycle. All modied oligonucleotides were charac-
terised by electrospray and/or MALDI mass spectrometry which
gave molecular ion masses (with appropriate isotope distribu-
tion patterns) consistent with the single-stranded sequence and
if self-complimentary, the corresponding duplex. No M+16
peaks were apparent in these spectra suggesting that either the
oxidation conditions did not lead to oxygen transfer to selenium
or that downstream processing of such modied oligomers
leads to their removal. This was further conrmed by 31P NMR
analysis of a double-labelled model pentamer.
Unlike previous generations of DNA analogues in which
selenium is introduced within the sugar moiety, the phos-
phoroselenolate modication described here is readily acces-
sible requiring only four high yielding steps and does not
require handling highly air-sensitive materials. Furthermore,
the furanose pseudorotation angles of the most common
modication, 20-SeMe, typically results in conformational
steering towards an A-form duplex. Using the related 20-SMe
analogue, such conformational restrictions were not observed
and both A- and B-DNA duplex crystal structures were solved82,83
although longer collection times (and concomitant DNA
damage) are associated with the weaker anomalous scattering
from sulfur at the CuKa wavelength. Furthermore, both
analogues interfere with minor groove binding interactions.
Finally, the expeditious crystallisation processes observed using
other selenium-modied nucleic acids was maintained with the
phosphoroselenolate.
Selenium-SAD has recently been applied to the de novo
phasing of data generated from an X-ray-free electron laser
including serial femtosecond crystallography84,85 and therefore
oﬀers the potential to observe conformational changes within
nucleic acids during folding, recognition and processing.
The resistance of the internucleoside phosphoroselenolate
linkage towards the exonuclease activity of snake venom oﬀers
the potential to both facilitate in vivo activity of therapeutic
nucleic acid sequences86 and to probe biochemical processes in
the same fashion as have phosphorothiolate56,87 and we
envisage that the ability to label an oligonucleotide backbone
using 100% 77Se may provide a valuable tool for investigating
the biological processing of such materials.88 Towards these
future goals we are currently investigating the application ofThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinethis chemistry for the preparation of phosphoroselenolate-
linkages derived from other selenonucleoside analogues.
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